{"id":755,"date":"2018-12-29T13:40:23","date_gmt":"2018-12-29T18:40:23","guid":{"rendered":"https:\/\/research.cbc.osu.edu\/pei.3\/?p=755"},"modified":"2018-12-29T13:40:23","modified_gmt":"2018-12-29T18:40:23","slug":"entrada-therapeutics-press-releases","status":"publish","type":"post","link":"https:\/\/research.cbc.osu.edu\/pei.3\/2018\/12\/29\/entrada-therapeutics-press-releases\/","title":{"rendered":"Entrada Therapeutics Press Releases"},"content":{"rendered":"<ul>\n<li class=\"article-intro-title\"><a href=\"https:\/\/cen.acs.org\/business\/start-ups\/Intracellular-biologics-drug-delivery-startEntrada\/96\/web\/2018\/12\">Intracellular biologics drug delivery start-up Entrada launches with $59 million<\/a><\/li>\n<li class=\"primary mhl mtm mbm\"><a href=\"https:\/\/xconomy.com\/boston\/2018\/12\/18\/entrada-therapeutics-nabs-59m-for-drugs-that-gain-entry-to-cells\/\">Entrada Therapeutics Nabs $59M for Drugs that Gain \u201cEntry\u201d to Cells<\/a><\/li>\n<li><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/entrada-emerges-59m-to-fund-delivery-biologic-therapies-into-cell\">Entrada emerges with $59M to fund the delivery of biologic therapies into the cell<\/a><\/li>\n<li><a href=\"https:\/\/endpts.com\/entrada-launches-today-taking-a-59m-shot-at-some-tough-intracellular-targets\/\">Entrada launches today, taking a $59M shot at some tough intracellular targets<\/a><\/li>\n<li><a href=\"https:\/\/www.bizjournals.com\/boston\/news\/2018\/12\/18\/boston-biotech-entrada-launches-with-59m-to-tackle.html\">Boston biotech Entrada launches with $59M to tackle deadly disease<\/a><\/li>\n<li><a href=\"https:\/\/www.bostonglobe.com\/business\/2018\/12\/18\/entrada-therapeutics-launches-with-million-funding\/0fUkikQ1tlHmtpv36u30mM\/story.html\">Entrada Therapeutics launches with $59 million in VC funding<\/a><\/li>\n<li><a href=\"https:\/\/www.biocentury.com\/bc-extra\/financial-news\/2018-12-18\/entrada-raises-59m-series-take-intracellular-biologic-clinic\">ENTRADA RAISES $59M SERIES A TO TAKE INTRACELLULAR BIOLOGIC INTO CLINIC<\/a><\/li>\n<li><a href=\"https:\/\/www.biospace.com\/article\/a-trio-of-companies-launch-today-to-target-cancer-mitochondria-and-hearing-loss\/?keywords=entrada\">A Trio of Companies Launch Today to Target Cancer, Mitochondria, and Hearing Loss<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Intracellular biologics drug delivery start-up Entrada launches with $59 million Entrada Therapeutics Nabs $59M for Drugs that Gain \u201cEntry\u201d to Cells Entrada emerges with $59M to fund the delivery of biologic therapies into the cell Entrada launches today, taking a $59M shot at some tough intracellular targets Boston biotech Entrada launches with $59M to tackle<\/p>\n<p><a href=\"https:\/\/research.cbc.osu.edu\/pei.3\/2018\/12\/29\/entrada-therapeutics-press-releases\/\" class=\"more-link themebutton\">Read More<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-755","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p6vtp5-cb","_links":{"self":[{"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/posts\/755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/comments?post=755"}],"version-history":[{"count":1,"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/posts\/755\/revisions"}],"predecessor-version":[{"id":756,"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/posts\/755\/revisions\/756"}],"wp:attachment":[{"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/media?parent=755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/categories?post=755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/research.cbc.osu.edu\/pei.3\/wp-json\/wp\/v2\/tags?post=755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}